文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

瑞典COVID-19第一波期间结直肠癌治疗及短期结局趋势

Trends in Treatment of Colorectal Cancer and Short-term Outcomes During the First Wave of the COVID-19 Pandemic in Sweden.
PubMed 文献 · JAMA Netw Open · 2022-05-02
一句话结论瑞典登记队列显示2020年3–8月结直肠癌诊断减少(550 vs 590例),结肠癌造口比例由17%升至30%,住院医师参与手术比例下降(35% vs 27%)。

该研究基于瑞典结直肠癌登记库,纳入斯德哥尔摩-哥特兰地区2019年3月1日至8月31日和2020年同期诊断的结直肠癌患者共1140例,比较COVID-19第一波期间与前一年的治疗和短期结局。2020年诊断患者数少于2019年(550 vs 590例),治疗前T4肿瘤比例升高(30% vs 22%,P<.001);腹腔镜手术比例、手术等待时间和30天并发症相似,但造口比例几乎翻倍(17% vs 30%,绝对风险13.0%,95%CI 6.8%–20.0%),住院医师参与切除比例下降(35% vs 27%,绝对风险-7.90%,95%CI -15.00%至-0.55%);直肠癌治疗和结局两年相当。作者认为这些变化最可能旨在减少并发症和重症监护需求。

要点

  • 2020年3–8月结直肠癌诊断550例,少于2019年同期590例,治疗前T4肿瘤比例由22%(132例)升至30%(172例)(χ²₃=21.1,P<.001)。
  • 结肠癌造口比例由2019年17%(53例)升至2020年30%(96例),绝对风险13.0%(95%CI 6.8%–20.0%)。
  • 住院医师参与切除手术比例由2019年35%(108例)降至2020年27%(83例),绝对风险-7.90%(95%CI -15.00%至-0.55%)。
  • 腹腔镜手术比例、手术等待时间和30天并发症两年相似;直肠癌治疗和结局两年相当。
  • 2020年更多患者被转至该地区非急诊、无COVID医院。

适用人群与场景

  • 瑞典斯德哥尔摩-哥特兰地区(瑞典6个医疗区域之一,约全国五分之一人口,8所医院)2019年3月1日至8月31日和2020年3月1日至8月31日诊断的结直肠癌患者,共1140例(男性583例[51%];2019年中位[IQR]年龄74[26-99]岁,2020年73[24-96]岁)。

研究设计与关键结果

  • 登记库队列研究:2020年3–8月诊断550例 vs 2019年同期590例;两组患者总体特征相似。
  • 治疗前T4肿瘤比例2020年30%(172例) vs 2019年22%(132例)(χ²₃=21.1;P<.001)。
  • 造口比例由2019年17%(53例)升至2020年30%(96例),绝对风险13.0%(95%CI 6.8%–20.0%)。
  • 住院医师参与切除手术比例2020年27%(83例) vs 2019年35%(108例),绝对风险-7.90%(95%CI -15.00%至-0.55%)。
  • 腹腔镜手术比例、手术等待时间和30天并发症两年相似;直肠癌治疗和结局两年相当;2020年更多患者被转至该地区非急诊、无COVID医院。

证据类型、等级与局限

  • 证据类型:登记库队列研究(瑞典结直肠癌登记库)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,结肠癌造口比例增加和住院医师参与手术减少最可能旨在减少并发症和重症监护需求。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: The COVID-19 pandemic has had a large impact on health care systems, not least the treatment of malignant diseases, including colorectal cancer.

OBJECTIVE: To investigate the treatment of colorectal cancer and short-term outcomes during the first wave of the COVID-19 pandemic, compared with the year before.

DESIGN, SETTING, AND PARTICIPANTS: This register-based cohort study used information from the Swedish Colorectal Cancer Registry during the years 2020 and 2019. Patients were from the Stockholm-Gotland region, 1 of 6 health care regions in Sweden, with approximately one-fifth of the country's population and 8 hospitals. All patients with a diagnosis of colorectal cancer from March 1 to August 31, 2019, and March 1 to August 31, 2020, were eligible. Data were analyzed from May to June 2021.

EXPOSURES: Diagnosis of colorectal cancer during the peak of the COVID-19 pandemic in 2020.

MAIN OUTCOMES AND MEASURES: The study aimed to compare the number of patients, time to surgery, operation methods, short-term complications, and residents' involvement in surgical practice between 2019 and 2020. Subanalyses were conducted for colon and rectal cancer.

RESULTS: A total of 1140 patients (583 men [51%]; median [IQR] age, 74 [26-99] years in 2019 and 73 [24-96] years in 2020) were enrolled. Fewer patients received a diagnosis of colorectal cancer in March through August 2020 compared with the same months in 2019 (550 vs 590 patients). Overall, patient characteristics were similar, but pretherapeutic tumor stage was more advanced in 2020 compared with 2019, with an increased proportion of T4 tumors (30% [172 patients] vs 22% [132 patients]; χ23 = 21.1; P < .001). The proportion of patients undergoing laparoscopic surgery, time to surgery, and 30-day complications were similar, but the proportion of patients treated with ostomy almost doubled between 2019 and 2020, from 17% (53 patients) to 30% (96 patients) (absolute risk, 13.0%; 95% CI, 6.8% to 20.0%). Residents participated in fewer resections in 2020 than in 2019 (35% [108 patients] vs 27% [83 patients]; absolute risk, -7.90%; 95% CI, -15.00% to -0.55%). On the other hand, the treatment and outcomes for rectal cancer were comparable between the years. Significantly more patients were transferred to the nonemergency, COVID-free hospital in the region in 2020.

CONCLUSIONS AND RELEVANCE: In this Swedish register-based cohort study of patients who received a diagnosis of colorectal cancer during the most intense period of the COVID-19 pandemic, a significant increase in ostomy formation for patients with colon cancer and a lower participation of residents during surgery were observed. These changes most likely were aimed at reducing complications and intensive care unit care.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Eklöv K, Nygren J, Bringman S, et al. Trends in Treatment of Colorectal Cancer and Short-term Outcomes During the First Wave of the COVID-19 Pandemic in Sweden. JAMA Netw Open. 2022. PMID: 35532933. doi:10.1001/jamanetworkopen.2022.11065

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。